Table 1.

Registered Exosome and Extracellular Vesicles Clinical Trials for COVID-19 on clinicaltrials.gov

No	NCT Number	Interventions	Phases	Enrollment	URL
1	NCT04491240	Exosome inhalation	Phase 1|Phase 2	90	https://ClinicalTrials.gov/show/NCT04491240
2	NCT04389385	COVID-19 Specific T Cell derived exosomes (CSTC- Exosome)	Phase 1	60	https://ClinicalTrials.gov/show/NCT04389385
3	NCT04384445	Zofin ® (Organcell™ Flow)Placebo	Phase 1|Phase 2	20	https://ClinicalTrials.gov/show/NCT04384445
4	NCT04493242	Bone marrow-derived extracellular vesicles	Phase 2	60	https://ClinicalTrials.gov/show/NCT04493242
5	NCT04276987	MSCs-derived exosomes	Phase 1	30	https://ClinicalTrials.gov/show/NCT04276987
6	NCT04623671	CAP-1002 Allogeneic cardiosphere-derived stem cell (CDC)	Phase 2	60	https://ClinicalTrials.gov/show/NCT04623671
7	NCT04595903	Hemopurifier ® device	Not Applicable	40	https://ClinicalTrials.gov/show/NCT04595903
8	NCT04602442	Exosome inhalation	Phase 2	90	https://ClinicalTrials.gov/show/NCT04602442